{"product_id":"test-salivaire-6-drogues","title":"Teste Salivar 6 Drogas Drugdiag® Saliva 6+","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag Saliva 6+\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste salivar 6 drogas com benzodiazepinas\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® Saliva 6+: teste salivar THC, cocaína, anfetaminas, metanfetaminas, MDMA e benzodiazepinas\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n O \u003cstrong\u003eteste salivar Drugdiag® Saliva 6+\u003c\/strong\u003e, concebido pelo \u003cstrong\u003elaboratório francês Toda Pharma\u003c\/strong\u003e, é o dispositivo de rastreio salivar mais completo da nossa gama. Permite procurar numa única análise \u003cstrong\u003e6 famílias de substâncias\u003c\/strong\u003e na saliva.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Deteta \u003cstrong\u003eTHC\u003c\/strong\u003e, \u003cstrong\u003ecocaína (COC)\u003c\/strong\u003e, \u003cstrong\u003eanfetaminas (AMP)\u003c\/strong\u003e, \u003cstrong\u003emetanfetaminas (MET)\u003c\/strong\u003e, \u003cstrong\u003eMDMA \/ ecstasy\u003c\/strong\u003e e \u003cstrong\u003ebenzodiazepinas (BZO)\u003c\/strong\u003e, com um limiar específico de \u003cstrong\u003e30 ng\/mL\u003c\/strong\u003e para as benzodiazepinas.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Disponível \u003cstrong\u003eà unidade\u003c\/strong\u003e ou em \u003cstrong\u003ecaixa de 25 testes\u003c\/strong\u003e, destina-se a particulares, empresas, profissionais de saúde, agentes de prevenção e estruturas que pretendam dispor de um rastreio salivar rápido, higiénico e alargado.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003e6 famílias detetadas na saliva\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFoco benzodiazepinas a 30 ng\/mL\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eÀ unidade ou em caixa de 25 testes\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 famílias salivares\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstâncias detetadas\u003c\/h2\u003e\n\n \u003cp\u003e\n O Drugdiag® Saliva 6+ procura seis famílias de substâncias diretamente na saliva, com uma leitura rápida e não invasiva.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis:\u003c\/strong\u003e Δ9-THC, canábis, resina, flores, produtos contendo THC ou vestígios residuais de THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e15 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e cocaína, coke, pó, crack e substâncias relacionadas detetáveis na saliva.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e20 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e anfetaminas, speed, pep e estimulantes relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e meth, crystal meth, ice e derivados relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA, ecstasy, taz, tata, molly e substâncias relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas:\u003c\/strong\u003e família de medicamentos ansiolíticos ou hipnóticos, incluindo nomeadamente Xanax®, Valium®, Lexomil® ou moléculas relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e30 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O painel BZO é um ponto diferenciador deste teste salivar. Permite alargar o rastreio a uma família de substâncias que podem causar sonolência, alteração da vigilância ou efeitos incompatíveis com certas atividades de risco.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eCondução, empresa, prevenção\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eUma proteção alargada para a sua segurança\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eSegurança rodoviária\u003c\/h3\u003e\n \u003cp\u003e\n Este teste permite um auto-controle alargado antes de conduzir, procurando THC, cocaína, anfetaminas, metanfetaminas, MDMA e benzodiazepinas. A presença de certas substâncias ou medicamentos pode alterar significativamente a vigilância ao volante.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenção nas empresas\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® Saliva 6+ pode ser integrado numa abordagem de prevenção em postos de segurança ou proteção, respeitando o regulamento interno, a proporcionalidade, a confidencialidade e o quadro legal aplicável.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eBenzodiazepinas e vigilância\u003c\/h3\u003e\n \u003cp\u003e\n A deteção de BZO permite considerar uma família frequentemente ausente dos testes padrão, embora possa estar associada a sonolência, perda de vigilância ou interações medicamentosas importantes.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenção e submissão química\u003c\/h3\u003e\n \u003cp\u003e\n Algumas benzodiazepinas podem estar envolvidas em situações de submissão química. Este teste pode ajudar a orientar uma verificação rápida, sem substituir um acompanhamento médico ou análises especializadas.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003ePor que escolher o Drugdiag® Saliva 6+?\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eEspectro alargado:\u003c\/strong\u003e 6 famílias pesquisadas numa única colheita salivar.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFoco BZO:\u003c\/strong\u003e deteção de benzodiazepinas com um limiar específico de 30 ng\/mL.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eColheita não invasiva:\u003c\/strong\u003e utilização simples, higiénica e rápida.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato flexível:\u003c\/strong\u003e disponível em unidade ou caixa com 25 testes.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante francês:\u003c\/strong\u003e dispositivo concebido pelo laboratório Toda Pharma, nº1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade profissional:\u003c\/strong\u003e marcação CE, ambiente de qualidade ISO 13485 e rastreabilidade dos lotes.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eConformidade salivar:\u003c\/strong\u003e produto conforme o decreto de 13 de dezembro de 2016.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cdiv class=\"ama-bsafe-alert\"\u003e\n \u003ch3\u003eBenzodiazepinas, medicamentos e condução\u003c\/h3\u003e\n \u003cp\u003e\n As benzodiazepinas incluem medicamentos frequentemente prescritos. Um resultado positivo pode ser coerente com um tratamento médico em curso, mas também pode indicar uma vigilância alterada dependendo da molécula, da dose e do contexto.\n \u003c\/p\u003e\n \u003cp\u003e\n Nunca altere um tratamento sem aconselhamento médico. Em caso de dúvida, consulte um profissional de saúde.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eLeitura e tratamentos\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eLeitura e interpretação\u003c\/h2\u003e\n\n \u003cp\u003e\n O Drugdiag® Saliva 6+ fornece um resultado analítico preliminar. Permite orientar rapidamente uma suspeita de consumo ou exposição, mas não substitui uma análise toxicológica laboratorial.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eResultado negativo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado negativo indica que as famílias pesquisadas não foram detetadas acima dos limiares do teste no momento da colheita. Isso não garante a ausência absoluta de qualquer substância.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado positivo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado positivo indica uma reação compatível com a presença de uma família pesquisada. Em contexto médico, profissional, oficial ou contestado, recomenda-se confirmação por método analítico laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado positivo para BZO em tratamento\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado positivo para benzodiazepinas pode ser esperado se a pessoa estiver em tratamento prescrito. Deve ser interpretado com cautela, respeitando o segredo médico e com o parecer de um profissional de saúde se necessário.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado inválido\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado inválido pode estar relacionado a uma má manipulação, colheita insuficiente ou não cumprimento do tempo de leitura. Deve-se então repetir o teste com um novo dispositivo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Os testes salivares detectam principalmente uma presença recente na saliva. A janela de deteção varia conforme a substância, dose, frequência, metabolismo, tempo decorrido e condições de colheita.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e conformidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e\n \u003cp\u003e\n O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConfiabilidade GC\/MS\u003c\/h3\u003e\n \u003cp\u003e\n A precisão deste dispositivo profissional de rastreio salivar foi comparada ao método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e\n \u003cp\u003e\n Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui marcação \u003cstrong\u003eCE\u003c\/strong\u003e, ambiente de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e rastreabilidade completa dos lotes.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003ePrincipais características\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste salivar multi-drogas de leitura rápida.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias pesquisadas :\u003c\/strong\u003e THC, COC, AMP, MET, MDMA, BZO.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eLimiar BZO :\u003c\/strong\u003e 30 ng\/mL.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eEmbalagem :\u003c\/strong\u003e disponível individualmente ou em caixa com 25 testes.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenção rodoviária, empresa, saúde, auto-controle e prevenção de riscos.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante :\u003c\/strong\u003e laboratório francês Toda Pharma, nº1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eConformidade :\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE, ISO 13485 e conformidade com a portaria de 13 de dezembro de 2016.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eProdutos de higiene e alimentares :\u003c\/strong\u003e café, chá, açúcar, enxaguante bucal, dentífrico, pastilha elástica, tabaco, bebidas gaseificadas.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns :\u003c\/strong\u003e ibuprofeno, paracetamol, aspirina, amoxicilina, xaropes antitússicos à base de dextrometorfano.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O teste deve ser utilizado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se a confirmação por análise laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eO que deteta o teste Drugdiag® Saliva 6+?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Deteta seis famílias de substâncias na saliva: \u003cstrong\u003eTHC\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e e \u003cstrong\u003eBZO\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eQual é a utilidade do painel benzodiazepinas?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n O painel BZO permite pesquisar uma família de medicamentos ansiolíticos ou hipnóticos que podem alterar a vigilância. Esta deteção é útil na prevenção rodoviária, em empresas e em certos contextos de suspeita de submissão química.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUm resultado positivo para benzodiazepinas significa necessariamente uso indevido?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Um resultado positivo pode estar relacionado com um tratamento médico prescrito. A interpretação deve sempre ter em conta o contexto, o segredo médico e, se necessário, o parecer de um profissional de saúde.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste está disponível individualmente?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim. O Drugdiag® Saliva 6+ está disponível individualmente para necessidades pontuais e em caixa de 25 testes para usos profissionais ou campanhas de rastreio.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste é adequado para empresas?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim, num quadro estritamente regulado: regulamento interno, postos de segurança, proporcionalidade, confidencialidade e respeito pelo direito do trabalho.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUm resultado positivo tem valor definitivo?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Um teste rápido fornece um resultado analítico preliminar. Em qualquer contexto oficial, médico, judicial, administrativo, disciplinar ou contestado, recomenda-se a confirmação por método analítico laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003ePrecisa de um conselho ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Pedir um orçamento\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e é um produto de saúde regulamentado com marcação CE. Fornece um resultado analítico preliminar e não substitui uma análise toxicológica laboratorial. Em caso de resultado positivo relacionado com um tratamento médico, consulte o seu médico. Nunca altere um tratamento sem aconselhamento médico.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434036036,"sku":"1046-SAL","price":26.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434068804,"sku":"1046-SAL","price":126.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 10","offer_id":56426434101572,"sku":"1046-SAL","price":239.0,"currency_code":"USD","in_stock":true},{"title":"Conjunto de 25","offer_id":56426434134340,"sku":"1046-SAL","price":534.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Image_produit_Drugdiag_Saliva_5.png?v=1777888267","url":"https:\/\/ama-prevention.com\/pt-pt\/products\/teste-saliva-6-drogas","provider":"AMA Prévention ","version":"1.0","type":"link"}